AgeX Therapeutics Inc. (AGE)
AMEX: AGE
· Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM
AgeX Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 7.5M | 2.88M | -7.65M | -17.47M | -20.96M | -14.81M | -14.11M | -11.16M | -11.1M | -10.52M | -9.92M | -9.44M | -9.3M | -8.58M | -8.88M | -9.49M | -9.75M |
Depreciation & Amortization | 200K | 208K | 138K | 91K | 123K | 131K | 131K | 131K | 132K | 132K | 132K | 131K | 131K | 131K | 675K | 1.01M | 1.35M |
Stock-Based Compensation | 4.03M | 3.13M | 1.63M | 619K | 631K | 648K | 259K | 428K | 591K | 760K | 909K | 972K | 1.06M | 999K | 918K | 878K | 851K |
Other Working Capital | -1.03M | -1.03M | n/a | 399K | 573K | 371K | -115K | 137K | 26K | 164K | -36K | -193K | -168K | -1.89M | -1.51M | -1.45M | -1.5M |
Other Non-Cash Items | -35.58M | -35.58M | -13.62M | 4.33M | 5.25M | 6.33M | 6.12M | 3.76M | 3.82M | 3.36M | 2.73M | 2.19M | 1.92M | 1.11M | 1.03M | 894K | 270K |
Deferred Income Tax | 1.64M | 1.64M | n/a | -909K | -1.11M | -1.11M | -374K | -199K | n/a | n/a | n/a | n/a | -437K | -633K | -572K | -558K | -82K |
Change in Working Capital | -1.37M | -1.37M | n/a | 901K | 774K | 1M | 908K | 602K | 391K | 329K | -121K | -764K | -234K | -884K | -998K | -569K | -1.02M |
Operating Cash Flow | -24.89M | -22.14M | -12.55M | -5.49M | -7.51M | -7.8M | -7.07M | -6.44M | -6.17M | -5.94M | -6.26M | -6.91M | -6.86M | -7.86M | -7.83M | -7.83M | -8.38M |
Capital Expenditures | -22K | -22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | 8K | 4K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -466K | -466K | -466K | n/a | 466K | 466K | 466K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 11K | -3K | -17K | -14K | -14K | -10M | -10M | -10M | -10M | n/a | 716K | 716K | 716K | 666K | -50K | -50K | -50K |
Investing Cash Flow | -11K | -25K | -17K | -14K | -14K | -10M | -10M | -10M | -10M | n/a | 250K | 250K | 250K | 666K | 436K | 424K | 420K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.13M | -1.13M | -1.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 48.51M | 51.24M | 11.33M | 6.73M | 8.73M | 17.5M | 17M | 16M | 16M | 6M | 5.75M | 6.75M | 6.25M | 7.25M | 6.99M | 6.96M | 8.27M |
Financial Cash Flow | 14.85M | 12.66M | 8.18M | 6.73M | 8.73M | 17.5M | 17M | 16M | 16M | 6M | 5.75M | 6.75M | 6.25M | 7.25M | 6.99M | 6.96M | 8.27M |
Net Cash Flow | n/a | 1.14M | 1.08M | 1.22M | 1.2M | -300K | -69K | -441K | -168K | 61K | -265K | 87K | -361K | 57K | -426K | -468K | 291K |
Free Cash Flow | -24.91M | -22.16M | -12.55M | -5.49M | -7.51M | -7.8M | -7.07M | -6.44M | -6.17M | -5.94M | -6.26M | -6.91M | -6.86M | -7.86M | -7.81M | -7.83M | -8.38M |